Futu Holdings Ltd vs Inovio Pharmaceuticals Inc — how do they compare? Futu Holdings Ltd trades at $105.85 (market cap $15.24B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $76.09M). The key difference: Futu Holdings Ltd is far larger — about 200.3× Inovio Pharmaceuticals Inc's market cap, and Futu Holdings Ltd pays a 2.39% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| FUTU | INO | |
|---|---|---|
Market Cap | $15.24B | $76.09M |
Sector | Financials | Health |
52-Week High | $199.04 | $2.87 |
52-Week Low | $89.76 | $0.66 |
Enterprise Value | $15.09B | $47.10M |
Dividend Yield | 2.39% | — |
Trailing returns across standard periods
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →